Physician profile
Sida Bai
NPI 1093283608
$4,251.92
in general payments reported to CMS, 2019-2025
27 companies · $689 in 2025
The $689 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $555 · 2022: $423 · 2023: $215 · 2024: $2,369 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,867 · Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,867.08 |
| Food and Beverage | $1,406.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,974.93 | 2022-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $653.36 | 2021-2025 | Ams 700 Cxr Rte Kit, Ams 700 |
| Janssen Biotech, INC. | $325.48 | 2021-2025 | Erleada, Balversa, Akeega |
| Myriad Genetic Laboratories, INC. | $278.45 | 2021-2023 | Prolaris |
| Coloplast Corp | $157.02 | 2021-2024 | Speedicath |
| Angiodynamics, INC. | $107.61 | 2025 | Nanoknife |
| Astellas Pharma US INC | $93.44 | 2021 | |
| Amgen INC. | $78.08 | 2021-2022 | |
| Antares Pharma, INC. | $63.65 | 2022-2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $55.35 | 2021-2025 | |
| Endo USA, INC. | $50.00 | 2024 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $50.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $48.91 | 2025 | |
| Merck Sharp & Dohme LLC | $41.49 | 2023 | Lynparza, Keytruda, Welireg |
| Sumitomo Pharma America, INC. | $34.96 | 2023-2025 | Orgovyx |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $31.89 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $30.22 | 2022 | |
| Medtronic, INC. | $29.81 | 2021 | |
| Urogen Pharma, INC. | $18.09 | 2025 | |
| Convatec INC. | $18.03 | 2024 | |
| Procept Biorobotics Corporation | $17.39 | 2022 | |
| Olympus America INC. | $17.06 | 2025 | Itind System |
| Pfizer INC. | $16.99 | 2022 | |
| Abc Home Medical Supply, INC. | $16.17 | 2025 | |
| Abbvie INC. | $15.95 | 2025 | |
| Tolmar, INC. | $14.80 | 2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sida Bai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.